Farber R - Search Results

1

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.

Auchus RJ, Hamidi O, Pivonello R, Bancos I, Russo G, Witchel SF, Isidori AM, Rodien P, Srirangalingam U, Kiefer FW, Falhammar H, Merke DP, Reisch N, Sarafoglou K, Cutler GB Jr, Sturgeon J, Roberts E, Lin VH, Chan JL, Farber RH; CAHtalyst Adult Trial Investigators. Auchus RJ, et al. Among authors: farber rh. N Engl J Med. 2024 Jun 1. doi: 10.1056/NEJMoa2404656. Online ahead of print. N Engl J Med. 2024. PMID: 38828955

2

Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.

Sarafoglou K, Kim MS, Lodish M, Felner EI, Martinerie L, Nokoff NJ, Clemente M, Fechner PY, Vogiatzi MG, Speiser PW, Auchus RJ, Rosales GBG, Roberts E, Jeha GS, Farber RH, Chan JL; CAHtalyst Pediatric Trial Investigators. Sarafoglou K, et al. Among authors: farber rh. N Engl J Med. 2024 Jun 2. doi: 10.1056/NEJMoa2404655. Online ahead of print. N Engl J Med. 2024. PMID: 38828945

3

Systematic review and meta-analysis of prognostic characteristics for breast cancers in populations with digital vs film mammography indicate the transition may have increased both early detection and overdiagnosis.

Farber R, Marinovich ML, Pinna A, Houssami N, McGeechan K, Barratt A, Bell KJL. Farber R, et al. J Clin Epidemiol. 2024 Apr 2;171:111339. doi: 10.1016/j.jclinepi.2024.111339. Online ahead of print. J Clin Epidemiol. 2024. PMID: 38570078 Free article.

4

Breast Cancer Stage and Size Detected with Film versus Digital Mammography in New South Wales, Australia: A Population-Based Study Using Routinely Collected Data.

Farber R, Houssami N, McGeechan K, Barratt A, Bell KJL. Farber R, et al. Cancer Epidemiol Biomarkers Prev. 2024 May 1;33(5):671-680. doi: 10.1158/1055-9965.EPI-23-0813. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38407377

5

The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation.

Farber RH, Stull DE, Witherspoon B, Evans CJ, Yonan C, Bron M, Dhanda R, Jen E, Brien CO'. Farber RH, et al. J Patient Rep Outcomes. 2024 Jan 4;8(1):2. doi: 10.1186/s41687-023-00679-4. J Patient Rep Outcomes. 2024. PMID: 38175450 Free PMC article.

6

Inflammatory vaginitis in four B-cell suppressed women with Multiple Sclerosis.

Levine L, Son J, Yu A, Wesley S, De Jager PL, Moynihan E, Farber RS, Rosser M, Haque H, Riley CS. Levine L, et al. Among authors: farber rs. Mult Scler Relat Disord. 2024 Feb;82:105387. doi: 10.1016/j.msard.2023.105387. Epub 2023 Dec 16. Mult Scler Relat Disord. 2024. PMID: 38134606

7

The impact of cross-jurisdictional patient flows on ascertainment of hospitalisations and cardiac procedures for ST-segment-elevation myocardial infarction in an Australian population.

Igic B, Farber R, Alfaro-Ramirez M, Nelson MA, Taylor LK. Igic B, et al. Among authors: farber r. Int J Popul Data Sci. 2023 Feb 8;8(1):1751. doi: 10.23889/ijpds.v8i1.1751. eCollection 2023. Int J Popul Data Sci. 2023. PMID: 37636833 Free PMC article.

8

Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2).

Klineova S, Farber RS, DeAngelis T, Leung T, Smith T, Blanck R, Zhovtis-Ryerson L, Harel A. Klineova S, et al. Among authors: farber rs. Mult Scler. 2023 Jul;29(8):990-1000. doi: 10.1177/13524585231185246. Mult Scler. 2023. PMID: 37431628 Free PMC article.

9

Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.

Newfield RS, Sarafoglou K, Fechner PY, Nokoff NJ, Auchus RJ, Vogiatzi MG, Jeha GS, Giri N, Roberts E, Sturgeon J, Chan JL, Farber RH. Newfield RS, et al. Among authors: farber rh. J Clin Endocrinol Metab. 2023 Oct 18;108(11):2871-2878. doi: 10.1210/clinem/dgad270. J Clin Endocrinol Metab. 2023. PMID: 37216921 Free PMC article.

10

Discrimination, Health, and Resistance for Thai Transgender Women.

Farber R. Farber R. J Racial Ethn Health Disparities. 2024 Apr;11(2):1124-1138. doi: 10.1007/s40615-023-01592-8. Epub 2023 May 10. J Racial Ethn Health Disparities. 2024. PMID: 37162741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page